|

Saline (0.9% NaCl) Clinical Trials

2 actively recruiting trials

Also known as: Placebo

Pipeline

Phase 2: 1

Top Sponsors

  • Asger Lund, MD1
  • Affiliated Hospital of Nantong University1

Indications

  • Coronary Arterial Disease (CAD)1
  • Type 1 Diabetes1
  • Coronary Heart Disease1
  • Heart Disease1
  • Coronary Artery Disease1

Other2 trials

Study of Sivelestat Sodium in OPCABG
Phase 2
The Effect of Endogenous GLP-1 on Glucagon Secretion in Type 1 Diabetes
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.